Inherited bleeding disorders and Zika virus infection
N. Gay,S. Azar,Ophira Salomon,Jason A. Taylor
DOI: https://doi.org/10.1111/hae.13315
2017-08-06
Haemophilia
Abstract:1. Duga S, Salomon O. Congenital factor XI deficiency: an update. Semin Thromb Hemost. 2013;39:621-631. 2. Petricevic M, Milicic D, Boban M, et al. Bleeding and thrombotic events in patients undergoing mechanical circulatory support: a review of literature. Thorac Cardiovasc Surg. 2015;63:636-646. 3. Bolton-Maggs PH, Perry DJ, Chalmers EA, et al. The rare coagulation disorders–review with guidelines for management from the United Kingdom Haemophilia Centre Doctors’ Organisation. Haemophilia. 2004;10:593-628. 4. Riddell A, Abdul-Kadir R, Pollard D, Tuddenham E, Gomez K. Monitoring low dose recombinant factor VIIa therapy in patients with severe factor XI deficiency undergoing surgery. Thromb Haemost. 2011;106:521-527. 5. Brunken R, Follette D, Wittig J. Coronary artery bypass in hereditary factor XI deficiency. Ann Thorac Surg. 1984;38:406-408. 6. Ingram MD, Torpey DJ Jr. Management of factor XI deficiency in coronary artery bypass graft surgery by plasmapheresis and exchange transfusion. J Cardiothorac Anesth. 1989;3:203-206. 7. Lammy S, Pessotto R. Factor XI deficiency: incidental diagnosis post coronary artery bypass graft. Scott Med J. 2014;59:e6-e8. 8. Watanabe S, Minagawa T, Kagatani T, Miura M, Tabayashi K. Aortic valve replacement in an elderly patient with factor XI deficiency. Gen Thorac Cardiovasc Surg. 2014;62:693-695. 9. Petroulaki A, Lazopoulos G, Chaniotaki F, Kampitakis E, Pavlopoulos D, Chalkiadakis G. Factor XI deficiency and aortic valve replacement: perioperative management. Asian Cardiovasc Thorac Ann. 2017;25:450-452. 10. Ponschab M, Landoni G, Biondi-Zoccai G, et al. Recombinant activated factor VII increases stroke in cardiac surgery: a metaanalysis. J Cardiothorac Vasc Anesth. 2011;25:804-810. 11. Livnat T, Tamarin I, Mor Y, et al. Recombinant activated factor VII and tranexamic acid are haemostatically effective during major surgery in factor XIdeficient patients with inhibitor antibodies. Thromb Haemost. 2009;102:487-492. 12. Watanabe S, et al. Aortic valve replacement in an elderly patient with factor XI deficiency. Gen Thorac Cardiovasc Surg. 2014;62:693–695. 13. Avci Z, et al. Successful use of recombinant factor VIIa (NovoSeven) during cardiac surgery in a pediatric patient with congenital factor XI deficiency. Pediatr Cardiol. 2008;29:220–222. 14. Teruya J, Styler M. Management of factor XI inhibitor for cardiac intervention: successful treatment with immunosuppressive therapy and plasma exchange. Haemophilia. 2000;6:158–161.